Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Hal who wrote (3808)	9/11/1998 12:27:00 PM
From: Lawrence Burg	Respond to of 3906

Does anyone here recall a Mr. Michael King or Princeton Research working in a promotional capacity for HVSF?

To: Hal who wrote (3808)	9/11/1998 1:33:00 PM
From: Amots	Read Replies (1) \| Respond to of 3906

As Batman said, they have the best copier... << U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 [ ] Check this box if no longer subject of Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ================================================================================ 1. Name and Address of Reporting Person* See, Jackie R. -------------------------------------------------------------------------------- (Last) (First) (Middle) 100 N. Arlington Ave., Suite 23P -------------------------------------------------------------------------------- (Street) Reno, NV 89501 -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker or Trading Symbol Harvard Scientific Corp. HVSF ================================================================================ 3. IRS or Social Security Number of Reporting Person (Voluntary) ================================================================================ 4. Statement for Month/Year 8/98 ================================================================================ 5. If Amendment, Date of Original (Month/Year) ================================================================================ 6. Relationship of Reporting Person to Issuer (Check all applicable) [ X ] Director [ X ] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) ================================================================================ 7. Individual or Joint/Group Filing (Check applicable line) [ X ] Form filed by one Reporting Person [ ] Form filed by more than one Reporting Person ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================ 6. 4. 5. Owner- Securities Acquired (A) or Amount of ship 3. Disposed of (D) Securities Form: 7. Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of 2. Code ------------------------------- Owned at End (D) or Indirect 1. Transaction (Instr. 8) (A) of Month Indirect Beneficial Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership (Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 8/27/98 S 1,000 D $5.25 I (1) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 8/28/98 S 1,000 D $5.00 I (1) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 8/31/98 S 500 D $4.625 I (1) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 8/31/98 S 500 D $4.50 I (1) ------------------------------------------------------------------------------------------------------------------------------------ 1,902,389 D/I (2) ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ==================================================================================================================================== * If the Form is filed by more than one Reporting Person, see Instruction 4(b)(v). Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Page 1 of 1 FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================ 9. 10. Number Owner- of ship 2. Deriv- of Conver- 5. 7. ative Deriv- 11. sion Number of Title and Amount Secur- ative Nature of Derivative 6. of Underlying 8. ities Secur- of Exer- 4. Securities Date Securities Price Bene- ity: In- cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene- 1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner- Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr. (Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4) ------------------------------------------------------------------------------------------------------------------------------------ Right to Purchase 296,302 D ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ==================================================================================================================================== Explanation of Responses: (1) Represents a sale of shares held by Bio-Sphere Technology, Inc. ("BTI"), a corporation in which Dr. See is officer, director and shareholder. (2) Reported holdings of non-derivative securities at month-end represent (a) 1,095,139 shares held by Dr. See in his individual capacity, (b) 707,250 shares held by BTI, and (c) 100,000 shares of Common Stock held by the Wassgren Anita See Trust, a trust in which Dr. See's spouse is the settlor and trustee (the "Trust"). Dr. See disclaims beneficial ownership in all shares held by BTI other than to the extent of his pecuniary interest therein and disclaims any beneficial ownership in all shares held by the Trust. Excludes 296,302 shares which Dr. See may be deemed to beneficially own by virtue of his right to exercise a purchase right disclosed in Table II of this Form, the acquisition of which was reported on a previously filed Form. /s/ Jackie R. See, M.D. 9/9/98 --------------------------------------------- ----------------------- Signature of Reporting Person Date Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedures. Alternatively, this Form is permitted to be submitted to the Commission in electronic format at the option of the reporting person pursuant to rule 101(b)(4) of Regulation S-T. Page 2 of 2 >> Amots P.S What happened to the hype machine? (Or when will they buy VVUS ?)